Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
12/12/1996 | WO1996039520A1 Human chemokine beta-12 |
12/12/1996 | WO1996039519A1 Kunitz type plasma kallikrein inhibitors |
12/12/1996 | WO1996039518A1 Lead binding polypeptides and nucleotides coding therefor |
12/12/1996 | WO1996039517A1 The erf genetic locus and its products |
12/12/1996 | WO1996039516A2 Targets for breast cancer diagnosis and treatment |
12/12/1996 | WO1996039515A1 Human vascular endothelial growth factor 2 |
12/12/1996 | WO1996039514A1 Method for prolonging the expression of a gene of interest using soluble ctla4 molecules |
12/12/1996 | WO1996039513A2 Ebnerin cloning of a secreted von ebner's gland protein |
12/12/1996 | WO1996039512A2 A cell line for the rapid expression of functional calcium channels |
12/12/1996 | WO1996039511A2 A C5a-LIKE SEVEN TRANSMEMBRANE RECEPTOR |
12/12/1996 | WO1996039510A1 Chimeric proteins for use in transport of a selected substance into cells |
12/12/1996 | WO1996039509A1 Fibroblast growth factor 15 |
12/12/1996 | WO1996039507A1 Fibroblast growth factor 11 |
12/12/1996 | WO1996039506A1 Fibroblast growth factor-14 |
12/12/1996 | WO1996039505A1 Avian ghd genes and their use in methods for sex identification in birds |
12/12/1996 | WO1996039504A2 Methods for distinguishing metastatic and non-metastatic cancers, polynucleotides and polypeptides for use therein |
12/12/1996 | WO1996039503A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY AND METHODS FOR PREPARATION |
12/12/1996 | WO1996039502A1 Oligonucleotides specific for hepatitis b virus |
12/12/1996 | WO1996039501A2 Oligonucleotides specific for human papillomavirus |
12/12/1996 | WO1996039500A2 Oligonucleotides specific for hepatitis c virus |
12/12/1996 | WO1996039499A1 TNF-α RIBOZYMES, TNF-α RIBOZYME BINDING PROTEIN AND DEGRADATION RESISTANT mRNA DERIVATIVES LINKED TO TNF-α RIBOZYMES |
12/12/1996 | WO1996039497A1 Transforming growth factor alpha hi |
12/12/1996 | WO1996039496A1 Use of neuro-derived fetal cell lines for transplantation therapy |
12/12/1996 | WO1996039495A1 Aav directed targeted integration |
12/12/1996 | WO1996039494A1 Method for expression and isolation of biologically active molecules in urine |
12/12/1996 | WO1996039491A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
12/12/1996 | WO1996039488A1 Process for controlling sialylation of proteins produced by mammalian cell culture |
12/12/1996 | WO1996039486A1 Human ccn-like growth factor |
12/12/1996 | WO1996039485A1 Human hepatoma-derived growth factor-2 |
12/12/1996 | WO1996039442A1 G-protein receptor htnad29 |
12/12/1996 | WO1996039441A1 Human g-protein receptor hibef51 |
12/12/1996 | WO1996039440A1 Human amine receptor |
12/12/1996 | WO1996039439A1 Human g-protein receptor hcegh45 |
12/12/1996 | WO1996039438A1 G-protein receptor hibeb69 |
12/12/1996 | WO1996039437A1 Human g-protein chemokine receptor hdgnr10 |
12/12/1996 | WO1996039435A1 Human g-protein receptor hpraj70 |
12/12/1996 | WO1996039434A1 Human g-protein receptor hgber32 |
12/12/1996 | WO1996039433A1 G-protein parathyroid hormone receptor hltdg74 |
12/12/1996 | WO1996039430A1 TGF-β FUSION PROTEINS AND THEIR USE IN WOUND HEALING |
12/12/1996 | WO1996039427A1 Ligand-stimulated gene expression |
12/12/1996 | WO1996039426A1 Hypoxia inducible factor-1 and method of use |
12/12/1996 | WO1996039423A2 A method for increasing the electrotransport flux of polypeptides |
12/12/1996 | WO1996039420A1 Human criptin growth factor |
12/12/1996 | WO1996039417A1 Chemical, biochemical and biological processing in thin films |
12/12/1996 | WO1996039415A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF raf GENE EXPRESSION |
12/12/1996 | WO1996039196A1 Gene transfer for treating a connective tissue of a mammalian host |
12/12/1996 | WO1996039195A2 Chemically modified oligonucleotide for site-directed mutagenesis |
12/12/1996 | WO1996039194A1 Novel cathepsin and methods and compositions for inhibition thereof |
12/12/1996 | WO1996039186A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits |
12/12/1996 | WO1996039185A1 Treatment and diagnosis of prostate cancer |
12/12/1996 | WO1996039179A1 Novel recombinant temperature sensitive mutants of influenza |
12/12/1996 | WO1996039178A1 A replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
12/12/1996 | WO1996039177A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
12/12/1996 | WO1996039172A1 Suppressor of hiv replication and transcription |
12/12/1996 | WO1996039162A1 Regulation of eating behavior |
12/12/1996 | WO1996039158A1 Pineal gland specific gene-1 |
12/12/1996 | WO1996039154A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/12/1996 | WO1996039152A1 Use of locally applied dna fragments |
12/12/1996 | WO1996039037A1 Methods for producing a potentiator of bacillus pesticidal activity |
12/12/1996 | WO1996039036A1 Composition and methods for creating syngeneic recombinant virus-producing cells |
12/12/1996 | WO1996039021A1 FbLATE PROMOTER |
12/12/1996 | WO1996039020A1 Genes conferring salt tolerance and their uses |
12/12/1996 | WO1996035788A3 Kunitz type protease inhibitors |
12/12/1996 | WO1996035785A3 Transgenic animals having a defective thyroid hormone receptor beta gene |
12/12/1996 | WO1996033282A3 High efficiency ex vivo transduction of cells by high titer recombinant retroviral preparations |
12/12/1996 | WO1996026293A3 Early recognition process of hpv-associated carcinomas or high-grade, hpv-caused dysplasias |
12/12/1996 | WO1996020732A3 Non-traumatic administration of gene delivery vehicles |
12/12/1996 | WO1996018733A3 Ribozyme-mediated inactivation of leukemia-associated rna |
12/12/1996 | WO1996011951A3 Keratinocyte growth factor analogs |
12/12/1996 | WO1996011949A3 Analogs of keratinocyte growth factor |
12/12/1996 | WO1996011266A3 Method for inhibiting smooth muscle cell proliferation and oligonucleotides for use therein |
12/12/1996 | DE19525900C1 Liver-specific adenovirus expression vector |
12/12/1996 | DE19520398A1 Magnetic particles with, opt. porous, glass surface |
12/12/1996 | CA2562211A1 Human g-protein chemokine receptor hdgnr10 |
12/12/1996 | CA2562162A1 Human g-protein chemokine receptor hdgnr10 |
12/12/1996 | CA2423891A1 Novel recombinant temperature sensitive mutants of influenza |
12/12/1996 | CA2413012A1 Human vascular endothelial growth factor 2 |
12/12/1996 | CA2226458A1 Oligonucleotides specific for hepatitis b virus |
12/12/1996 | CA2226438A1 Oligonucleotides specific for hepatitis c virus |
12/12/1996 | CA2224176A1 Gene transfer for treating a connective tissue of a mammalian host |
12/12/1996 | CA2224094A1 Human amine receptor |
12/12/1996 | CA2223957A1 Transforming growth factor alpha hi |
12/12/1996 | CA2223741A1 Aav directed targeted integration |
12/12/1996 | CA2223733A1 Human hepatoma-derived growth factor-2 |
12/12/1996 | CA2223707A1 Novel gene-up regulated in regenerating liver |
12/12/1996 | CA2223496A1 Chemical, biochemical and biological processing in thin films |
12/12/1996 | CA2223439A1 Anti-neutrophil cytoplasmic antibody material associated with ulcerative colitis and related methods and kits |
12/12/1996 | CA2223421A1 Methods for enhancement of protective immune responses |
12/12/1996 | CA2223419A1 Recombinant poxvirus-calicivirus [rabbit hemorrhagic disease virus (rhdv)] compositions and uses |
12/12/1996 | CA2223291A1 Treatment and diagnosis of prostate cancer |
12/12/1996 | CA2223282A1 Recombinant poxvirus - cytomegalovirus compositions and uses |
12/12/1996 | CA2223153A1 Regulation of eating behavior |
12/12/1996 | CA2223103A1 Oligonucleotides having phosphorothioate linkages of high chiral purity |
12/12/1996 | CA2223038A1 A c5a-like seven transmembrane receptor |
12/12/1996 | CA2222880A1 Recombinant adenovirus and adeno-associated virus, cell lines, and methods of production and use thereof |
12/12/1996 | CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1 |
12/12/1996 | CA2221795A1 Colon specific gene and protein |
12/12/1996 | CA2221711A1 Chimeric proteins for use in transport of a selected substance into cells |
12/12/1996 | CA2221706A1 G-protein receptor htnad29 |
12/12/1996 | CA2221684A1 Novel cathepsin and methods and compositions for inhibition thereof |